Roles of klotho and stem cells in mediating vascular calcification (Review)
- Authors:
- Liangzhu Yu
- Mincai Li
-
Affiliations: Hubei Key Laboratory of Cardiovascular, Cerebrovascular and Metabolic Disorders, Xianning, Hubei 437100, P.R. China - Published online on: September 24, 2020 https://doi.org/10.3892/etm.2020.9252
- Article Number: 124
This article is mentioned in:
Abstract
 |
 |
 |
|
Nicoll R and Henein M: Arterial calcification: A new perspective? Int J Cardiol. 228:11–22. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW and Kroon AA: Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis. Vasc Health Risk Manag. 5:185–197. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Kuro-o M: Klotho in health and disease. Curr Opin Nephrol Hypertens. 21:362–368. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kuro-o M: Klotho and the aging process. Korean J Intern Med. 26:113–122. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Leopold JA: Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 25:267–274. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ullah M and Sun Z: Klotho deficiency accelerates stem cells aging by impairing telomerase activity. J Gerontol A Biol Sci Med Sci. 74:1396–1407. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang W, Xue D, Hu D, Xie T, Tao Y, Zhu T, Chen E and Pan Z: Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway. Growth Factors. 33:356–365. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L and Xu Q: Stem/Progenitor cells in vascular regeneration. Arterioscler Thromb Vasc Biol. 34:1114–1119. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Campagnolo P, Wong MM and Xu Q: Progenitor cells in arteriosclerosis: Good or bad guys? Antioxid Redox Signal. 15:1013–1027. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xie C, Ouyang L, Chen J, Zhang H, Luo P, Wang J and Huang H: The emerging role of mesenchymal stem cells in vascular calcification. Stem Cells Int. 2019(2875189)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zou S, Ren P, Zhang L, Azares AR, Zhang S, Coselli JS, Shen YH and LeMaire SA: Activation of bone marrow-derived cells and resident aortic cells during aortic injury. J Surg Res. 245:1–12. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen Q, Yang M, Wu H, Zhou J, Wang W, Zhang H, Zhao L, Zhu J, Zhou B, Xu Q and Zhang L: Genetic lineage tracing analysis of c-kit+ stem/progenitor cells revealed a contribution to vascular injury-induced neointimal lesions. J Mol Cell Cardiol. 121:277–286. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Burtenshaw D, Hakimjavadi R, Redmond EM and Cahill PA: Nox, reactive oxygen species and regulation of vascular cell fate. Antioxidants (Basel). 14(90)2017.PubMed/NCBI View Article : Google Scholar | |
|
Bostrom KI: Where do we stand on vascular calcification? Vascul Pharmacol 2016:. 84:8–14. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Leszczynska A and Murphy JM: Vascular calcification: Is it rather a stem/progenitor cells driven phenomenon? Front Bioeng Biotechnol. 6(10)2018.PubMed/NCBI View Article : Google Scholar | |
|
Dzhoyashvili NA, Efimenko AY, Kochegura TN, Kalinina NI, Koptelova NV, Sukhareva OY, Shestakova MV, Akchurin RS, Tkachuk VA and Parfyonova YV: Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2. J Transl Med. 12(337)2014.PubMed/NCBI View Article : Google Scholar | |
|
Ikeda Y, Kumagai H, Motozawa Y, Suzuki J, Akazawa H and Komuro I: Understanding vascular diseases: Lessons from premature aging syndromes. Can J Cardiol. 32:650–658. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Khodayari S, Khodayari H, Amiri AZ, Eslami M, Farhud D, Hescheler J and Nayernia K: Inflammatory microenvironment of acute myocardial infarction prevents regeneration of heart with stem cells therapy. Cell Physiol Biochem. 53:887–909. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Fadini GP, Albiero M, Menegazzo L, Boscaro E, Agostini C, de Kreutzenberg SV, Rattazzi M and Avogaro A: Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res. 2012(921685)2012.PubMed/NCBI View Article : Google Scholar | |
|
Cianciolo G, Capelli I, Cappuccilli M, Scrivo A, Donadei C, Marchetti A, Rucci P and La Manna G: Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? Clin Kidney J. 10:389–396. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kramann R, Goettsch C, Wongboonsin J, Iwata H, Schneider RK, Kuppe C, Kaesler N, Chang-Panesso M, Machado FG, Gratwohl S, et al: Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell. 19:628–642. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J and Schneider RK: Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease. J Bone Miner Res. 28:2523–2534. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Zununi Vahed S, Mostafavi S, Hosseiniyan Khatibi SM, Shoja MM and Ardalan M: Vascular calcification: An important understanding in nephrology. Vasc Health Risk Manag. 16:167–180. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Guerrero F, Herencia C, Almaden Y, Martinez-Moreno JM, Montes de Oca A, Rodriguez-Ortiz ME, Diaz-Tocados JM, Canalejo A, Florio M, López I, et al: TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways. PLoS One. 9(e89179)2014.PubMed/NCBI View Article : Google Scholar | |
|
Evrard S, Delanaye P, Kamel S, Cristol JP and Cavalier E: SFBC/SN joined working group on vascular calcifications. Vascular calcification: From pathophysiology to biomarkers. Clin Chim Acta. 438:401–414. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang CL, Xiao F, Wang CD, Zhu JF, Shen C, Zuo B, Wang H, Li D, Wang XY, Feng WJ, et al: Gremlin2 suppression increases the BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells via the BMP-2/Smad/Runx2 signaling pathway. J Cell Biochem. 118:286–297. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Zhao X and Wu H: Arterial stiffness: A focus on vascular calcification and its link to bone mineralization. Arterioscler Thromb Vasc Biol. 40:1078–1093. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM and Chen Y: Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 283:15319–15327. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Sim HJ, Kim JH, Kook SH, Lee SY and Lee JC: Glucose oxidase facilitates osteogenic differentiation and mineralization of embryonic stem cells through the activation of Nrf2 and ERK signal transduction pathways. Mol Cell Biochem. 419:157–163. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sprague AH and Khalil RA: Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 78:539–552. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Shobeiri N and Bendeck MP: Interleukin-1β Is a key biomarker and mediator of inflammatory vascular calcification. Arterioscler Thromb Vasc Biol. 37:179–180. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Han L, Zhang Y, Zhang M, Guo L, Wang J, Zeng F, Xu D, Yin Z, Xu Y, Wang D and Zhou H: Interleukin-1β-induced senescence promotes osteoblastic transition of vascular smooth muscle cells. Kidney Blood Press Res. 45:314–330. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ciavarella C, Gallitto E, Ricci F, Buzzi M, Stella A and Pasquinelli G: The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm. Stem Cell Res Ther. 8(99)2017.PubMed/NCBI View Article : Google Scholar | |
|
Hegner B, Schaub T, Janke D, Zickler D, Lange C, Girndt M, Jankowski J, Schindler R and Dragun D: Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro. Sci Rep. 8(12087)2018.PubMed/NCBI View Article : Google Scholar | |
|
Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro-O M and Lang F: Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest. 123:812–822. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Lin Y and Sun Z: Deficiency in the anti-aging gene Klotho promotes aortic valve fibrosis through AMPKalpha-mediated activation of RUNX2. Aging Cell. 15:853–860. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sun H, Zhang F, Xu Y, Sun S, Wang H, Du Q, Gu C, Black SM, Han Y and Tang H: Salusin-β promotes vascular calcification via nicotinamide adenine dinucleotide phosphate/reactive oxygen species-mediated klotho downregulation. Antioxid Redox Signal. 31:1352–1370. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Fan J and Sun Z: The antiaging gene klotho regulates proliferation and differentiation of adipose-derived stem cells. Stem Cells. 34:1615–1625. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Vadakke Madathil S, Coe LM, Casu C and Sitara D: Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis. Am J Pathol. 184:827–841. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Bian A, Neyra JA, Zhan M and Hu MC: Klotho, stem cells, and aging. Clin Interv Aging. 10:1233–1243. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Bartoli-Leonard F, Wilkinson FL, Langford-Smith AWW, Alexander MY and Weston R: The interplay of SIRT1 and Wnt signaling in vascular calcification. Front Cardiovasc Med. 5(183)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J and He W: WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 345:206–217. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Wang W, Li C, Pang L, Shi C, Guo F, Chen A, Cao X and Wan M: Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification. Stem Cells Dev. 23:1392–1404. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Chen YX, Huang C, Duan ZB, Xu CY and Chen Y: Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway. Kaohsiung J Med Sci. 35:393–400. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 390:45–51. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Hum JM, O'Bryan LM, Tatiparthi AK, Cass TA, Clinkenbeard EL, Cramer MS, Bhaskaran M, Johnson RL, Wilson JM, Smith RC and White KE: Chronic hyperphosphatemia and vascular calcification are reduced by stable delivery of soluble klotho. J Am Soc Nephrol. 28:1162–1174. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Chen T, Mao H, Chen C, Wu L, Wang N, Zhao X, Qian J and Xing C: The role and mechanism of α-Klotho in the calcification of rat aortic vascular smooth muscle cells. Biomed Res Int. 2015(194362)2015.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Liu Y, Zhang Y, Bi X, Nie L, Liu C, Xiong J, He T, Xu X, Yu Y, et al: High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification. J Mol Cell Cardiol. 114:264–275. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chang JR, Guo J, Wang Y, Hou YL, Lu WW, Zhang JS, Yu YR, Xu MJ, Liu XY, Wang XJ, et al: Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho. Kidney Int. 89:586–600. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M and Moe OW: Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 22:124–136. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Golembiewska E, Stepniewska J, Kabat-Koperska J, Kedzierska K, Domanski M and Ciechanowski K: The role of klotho protein in chronic kidney disease: Studies in animals and humans. Curr Protein Pept Sci. 17:821–826. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kuro OM: The Klotho proteins in health and disease. Nat Rev Nephrol. 15:27–44. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Olejnik A, Franczak A, Krzywonos-Zawadzka A, Kaluzna-Oleksy M and Bil-Lula I: The biological role of klotho protein in the development of cardiovascular diseases. Biomed Res Int. 2018(5171945)2018.PubMed/NCBI View Article : Google Scholar | |
|
Henaut L, Chillon JM, Kamel S and Massy ZA: Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease. Semin Nephrol. 38:233–250. 2018.PubMed/NCBI View Article : Google Scholar |
